Metrics to compare | 002099 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002099PeersSector | |
|---|---|---|---|---|
P/E Ratio | −115.0x | −6.7x | −0.3x | |
PEG Ratio | −1.41 | 0.03 | 0.00 | |
Price/Book | 1.7x | 1.7x | 2.6x | |
Price / LTM Sales | 4.6x | 2.9x | 3.0x | |
Upside (Analyst Target) | - | 15.3% | 56.6% | |
Fair Value Upside | Unlock | −8.4% | 10.2% | Unlock |
Zhejiang Hisoar Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of active pharmaceutical ingredients (APIs) and pharmaceutical intermediates in China and internationally. It operates through Pharmaceutical Industry, Dye Industry, and Others segments. The company offers antibiotics, cardiovascular drugs, hypoglycemic agents, formulations, and fine chemicals. It also provides dyes and pigment intermediates; environmental protection-related equipment; medical chemical supplies and appliances; and other chemical intermediates. In addition, the company engages in technology research and development; trading; hazardous waste treatment; equity investment; technical consulting and other consulting services; and venture capital activities. It exports its products to approximately 30 countries, including Europe, America, and Asia. Zhejiang Hisoar Pharmaceutical Co., Ltd. was founded in 1966 and is headquartered in Taizhou, China.